This content is from: Premium Biopharma Funds Are Still Embracing VC The number of deals is down from last year, but most firms have still been fairly active in the private markets. By Stephen Taub December 21, 2022
This content is from: Premium It’s Been a Bad Year for IPOs — But Hedge Funds Are Betting on These New Offerings Three hedge funds were major investors in a biopharma company that recently went public. By Stephen Taub December 16, 2022
This content is from: Portfolio The IPO Market Is on Track for Its Worst Performance in 30 Years Venture capital and private equity have left the market, and the third quarter’s proceeds are the lowest since 2008. By Michelle Celarier September 30, 2022
Sponsored Renaissance Hires IB Co-Head Renaissance Capital has appointed John Hyman as co-head of investment banking and financing. October 11, 2011
Sponsored Renaissance Adds Asia Equity Group Head Renaissance Capital has recruited Ed Mason as head of its Asia equity product group. July 07, 2011
Sponsored Renaissance Names India IB Head Renaissance Capital has appointed Ateev Chadda as head of investment banking and financing in India. August 10, 2011
